118 related articles for article (PubMed ID: 10855376)
1. [Use of methadone as analgesic].
Donnadieu S
Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A40-3. PubMed ID: 10855376
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
4. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
[TBL] [Abstract][Full Text] [Related]
5. [Methadone as an analgesic].
Kamp-Jensen M; Clausen T; Eriksen J
Ugeskr Laeger; 2000 Jan; 162(2):163-6. PubMed ID: 10647313
[TBL] [Abstract][Full Text] [Related]
6. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
7. Methadone: an effective alternative to morphine for pain relief in cancer patients.
Shelton BW; Deynes-Romero J; Tofani-Montalvo M; Ramírez-Rivera J; Jaumne-Anselmi F
Bol Asoc Med P R; 2008; 100(3):7-10. PubMed ID: 19227708
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
Auret K; Roger Goucke C; Ilett KF; Page-Sharp M; Boyd F; Oh TE
Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
[TBL] [Abstract][Full Text] [Related]
9. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
10. Methadone treatment for pain states.
Toombs JD; Kral LA
Am Fam Physician; 2005 Apr; 71(7):1353-8. PubMed ID: 15832538
[TBL] [Abstract][Full Text] [Related]
11. The role of methadone in cancer pain treatment--a review.
Leppert W
Int J Clin Pract; 2009 Jul; 63(7):1095-109. PubMed ID: 19570126
[TBL] [Abstract][Full Text] [Related]
12. A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size.
Lötsch J; Prüss H; Veh RW; Doehring A
Pharmacogenet Genomics; 2010 May; 20(5):291-7. PubMed ID: 20220551
[TBL] [Abstract][Full Text] [Related]
13. The rediscovery of methadone for cancer pain management.
Ayonrinde OT; Bridge DT
Med J Aust; 2000 Nov; 173(10):536-40. PubMed ID: 11194738
[TBL] [Abstract][Full Text] [Related]
14. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
15. Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy.
Meyer M; Wagner K; Benvenuto A; Plante D; Howard D
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):261-6. PubMed ID: 17666599
[TBL] [Abstract][Full Text] [Related]
16. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
17. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
18. Effects of LAAM and methadone utilization in an opiate agonist treatment program.
Valdivia JF; Khattak S
Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490
[TBL] [Abstract][Full Text] [Related]
19. (S)-(+)-methadone is more immunosuppressive than the potent analgesic (R)-(--)-methadone.
Hutchinson MR; Somogyi AA
Int Immunopharmacol; 2004 Nov; 4(12):1525-30. PubMed ID: 15351321
[TBL] [Abstract][Full Text] [Related]
20. Analgesic effects of subarachnoidally administered hyperbaric opioids in horses.
Natalini CC; Polydoro Ada S; Linardi RL
Am J Vet Res; 2006 Jun; 67(6):941-6. PubMed ID: 16740084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
